[(2R)-2-[(2R,4R)-3,4-dihydroxy-5-oxooxolan-2-yl]-2-hydroxyethyl] dihydrogen phosphate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磷酸及其衍生物
• 英文名称: [(2R)-2-[(2R,4R)-3,4-dihydroxy-5-oxooxolan-2-yl]-2-hydroxyethyl] dihydrogen phosphate
• 化学式: C₆H₁₁O₉P
• 分子量: 258.12
• InChiKey: LVSTZAQFDDWMSO-NLJOEYPJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.1
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  154
• 氢给体数：
  5
• 氢受体数：
  9

文献信息

• [EN] NEW ANTIBACTERIAL COMPOUNDS AND BIOLOGICAL APPLICATIONS THEREOF<br/>[FR] NOUVEAUX COMPOSÉS ANTIBACTÉRIENS ET LEURS APPLICATIONS BIOLOGIQUES
  申请人：BIODIM LAB

  公开号：WO2014067904A1

  公开（公告）日：2014-05-08

  The invention relates to compounds of formulae (Ia), (Ib) or (Ic) wherein, - A1 and A2, identical or different, are H, (C1-C6) alkyl, (C1-C6) fluoroalkyl, (C2-C6) alkenyl, (C2-C6) alkynyl, (C1-C6) alkyl-ORa, (C1-C6) alkyl-SRa, (C1-C6) alkyl-NRaRb, ORa, SRa, NRaRb, or CORa; - A3 is H, OH or form a carbonyl with A4; - A4 is H, OH or form a carbonyl with A3; - A5 is H, CRaRbOH, F, OH or forms a double bond with X in the case where X is CH; - A6 is H or F; - X is CH2, CHF, CF2, CHOH, O, S, NRa or a simple bond, or X is CH in the case where A5 forms with X a double bond; - Y is P(O) (ORa) (ORb) or P (O) (ORa) (NRaRb); - V is O or S; - A7 is H, (C1-C6) alkyl, (C1-C6) fluoroalkyl, (C2-C6) alkenyl, (C2-C6) alkynyl or (C1-C6) alkyl-ORa; - A8 is OH or H, - Ra and Rb, identical or different, are H, (C1-C6) alkyl, (C1-C6) fluoroalkyl, (C1-C6) alkyl-OH or (C1-C6) alkyl-O- (C1- C6) alkyl; and their addition salts thereof with acids and bases, their preparation and their use in the antibacterial prevention and therapy, used alone or in association with antibacterials, antivirulence agents or drugs reinforcing the host innate immunity.

  该发明涉及以下式(Ia)、(Ib)或(Ic)的化合物，其中，- A1和A2，相同或不同，为H、(C1-C6)烷基、(C1-C6)氟烷基、(C2-C6)烯基、(C2-C6)炔基、(C1-C6)烷基-ORa、(C1-C6)烷基-SRa、(C1-C6)烷基-NRaRb、ORa、SRa、NRaRb或CORa；- A3为H、OH或与A4形成羰基；- A4为H、OH或与A3形成羰基；- A5为H、CRaRbOH、F、OH或与X形成双键，其中X为CH时；- A6为H或F；- X为CH2、CHF、CF2、CHOH、O、S、NRa或简单键，或当A5与X形成双键时X为CH；- Y为P(O)(ORa)(ORb)或P(O)(ORa)(NRaRb)；- V为O或S；- A7为H、(C1-C6)烷基、(C1-C6)氟烷基、(C2-C6)烯基、(C2-C6)炔基或(C1-C6)烷基-ORa；- A8为OH或H；- Ra和Rb，相同或不同，为H、(C1-C6)烷基、(C1-C6)氟烷基、(C1-C6)烷基-OH或(C1-C6)烷基-O-(C1-C6)烷基；以及它们与酸和碱的加成盐，它们的制备以及它们在抗菌预防和治疗中的用途，单独使用或与抗菌剂、抗毒力剂或增强宿主先天免疫力的药物结合使用。
• New antibacterial compounds and biological applications thereof
  申请人：LABORATOIRE BIODIM

  公开号：EP2725029A1

  公开（公告）日：2014-04-30

  The invention relates to compounds of formula (I) wherein, - A1 and A2, identical or different, are H, (C1-C6) alkyl, (C1-C6) fluoroalkyl, (C2-C6) alkenyl, (C2-C6) alkynyl, (C1-C6) alkyl-ORa, (C1-C6) alkyl-SRa, (C1-C6) alkyl-NRaRb, ORa, SRa, NRaRb, or CORa; - A3 is H, OH or form a carbonyl with A4; - A4 is H, OH or form a carbonyl with A3; - A5 is H, OH, CRaRbOH or F; - A6 is H or F; - X is CH2, CHF, CF2, CHOH, O, S, NRa or a simple bond; - Y is P(O) (ORa) (ORb) or P(O) (ORa) (NRaRb) ; - V is O or S; - A7 is H, (C1-C6) alkyl, (C1-C6) fluoroalkyl, (C2-C6) alkenyl, (C2-C6) alkynyl or (C1-C6) alkyl-ORa; - Ra and Rb, identical or different, are selected from the group consisting of H, (C1-C6) alkyl, (C1-C6) fluoroalkyl, (C1-C6) alkyl-OH and (C1-C6) alkyl-O-(C1-C6) alkyl; and their addition salts thereof with acids and bases, their preparation and their use in the antibacterial prevention and therapy, used alone or in association with antibacterials, antivirulence agents or drugs reinforcing the host innate immunity.

  该发明涉及式（I）的化合物，其中，- A1和A2，相同或不同，为H，（C1-C6）烷基，（C1-C6）氟烷基，（C2-C6）烯基，（C2-C6）炔基，（C1-C6）烷基-ORa，（C1-C6）烷基-SRa，（C1-C6）烷基-NRaRb，ORa，SRa，NRaRb或CORa；- A3为H，OH或与A4形成羰基；- A4为H，OH或与A3形成羰基；- A5为H，OH，CRaRbOH或F；- A6为H或F；- X为CH2，CHF，CF2，CHOH，O，S，NRa或简单键；- Y为P(O)(ORa)(ORb)或P(O)(ORa)(NRaRb)；- V为O或S；- A7为H，（C1-C6）烷基，（C1-C6）氟烷基，（C2-C6）烯基，（C2-C6）炔基或（C1-C6）烷基-ORa；- Ra和Rb，相同或不同，选自H，（C1-C6）烷基，（C1-C6）氟烷基，（C1-C6）烷基-OH和（C1-C6）烷基-O-（C1-C6）烷基的群；以及它们与酸和碱的加合盐，它们的制备以及它们在抗菌预防和治疗中的应用，单独使用或与抗菌剂、抗毒力剂或增强宿主固有免疫的药物联合使用。
• ANTIBACTERIAL COMPOUNDS AND BIOLOGICAL APPLICATIONS THEREOF
  申请人：LABORATOIRE BIODIM

  公开号：US20150291636A1

  公开（公告）日：2015-10-15

  The invention relates to compounds of formulae (Ia), (Ib) or (Ic) wherein, A 1 and A 2 , identical or different, are H, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) fluoroalkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 1 -C 6 ) alkyl-OR a , (C 1 -C 6 ) alkyl-SR a , (C 1 -C 6 ) alkyl-NR a R b , OR a , SR a , NR a R b , or COR a ; A 3 is H, OH or form a carbonyl with A 4 ; A 4 is H, OH or form a carbonyl with A 3 ; A 5 is H, CR a R b OH, F, OH or forms a double bond with X in the case where X is CH; A 6 is H or F; X is CH 2 , CHF, CF 2 , CHOH, O, S, NR a or a simple bond, or X is CH in the case where A 5 forms with X a double bond; Y is P(O)(OR a )(OR b ) or P(O)(OR a )(NR a R b ); V is O or S; A 7 is H, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) fluoroalkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl or (C 1 -C 6 ) alkyl-OR a ; A 8 is OH or H, R a and R b , identical or different, are H, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) fluoroalkyl, (C 1 -C 6 ) alkyl-OH or (C 1 -C 6 ) alkyl-O—(C 1 -C 6 ) alkyl; and their addition salts thereof with acids and bases, their preparation and their use in the antibacterial prevention and therapy, used alone or in association with antibacterials, antivirulence agents or drugs reinforcing the host innate immunity.

  本发明涉及式(Ia)、(Ib)或(Ic)化合物，其中A1和A2，相同或不同，是H、(C1-C6)烷基、(C1-C6)氟烷基、(C2-C6)烯基、(C2-C6)炔基、(C1-C6)烷基-ORa、(C1-C6)烷基-SRa、(C1-C6)烷基-NRaRb、ORa、SRa、NRaRb或CORa；A3是H、OH或与A4形成羰基；A4是H、OH或与A3形成羰基；A5是H、CRaRbOH、F、OH或在X为CH的情况下与X形成双键；A6是H或F；X是CH2、CHF、CF2、CHOH、O、S、NRa或简单键，或在A5与X形成双键的情况下X是CH；Y是P(O)(ORa)(ORb)或P(O)(ORa)(NRaRb)；V是O或S；A7是H、(C1-C6)烷基、(C1-C6)氟烷基、(C2-C6)烯基、(C2-C6)炔基或(C1-C6)烷基-ORa；A8是OH或H，Ra和Rb，相同或不同，是H、(C1-C6)烷基、(C1-C6)氟烷基、(C1-C6)烷基-OH或(C1-C6)烷基-O-(C1-C6)烷基；以及它们与酸和碱的加成盐，它们的制备和在抗菌预防和治疗中的使用，单独使用或与抗菌剂、抗毒力剂或增强宿主先天免疫的药物联用。
• NEW ANTIBACTERIAL COMPOUNDS AND BIOLOGICAL APPLICATIONS THEREOF
  申请人：Mutabilis

  公开号：EP2912043B1

  公开（公告）日：2016-11-30